 PALO ALTO, Calif., April 01, 2021 GLOBE NEWSWIRE -- Vincerx Pharma, Inc. Nasdaq: VINC, a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced the formation of its Scientific Advisory Board SAB composed of world leading academics and industry leaders in cancer research and therapeutics. John C. Byrd, M.D., will serve as Chairman of the SAB. 